Abu Dhabi releases longevity health blueprint at BIO 2026

Abu Dhabi wants to be known for more than oil wealth and skyscrapers. The emirate is making a serious push to become a global hub for longevity medicine, and it just published a detailed roadmap explaining how it plans to get there.

Future Health, a global health initiative backed by Abu Dhabi, released a whitepaper titled "The Future of Longevity: Extending Healthspan" at the BIO International Convention 2026 in San Diego. The document lays out Abu Dhabi's approach to one of the most pressing problems in modern healthcare: people are living longer, but those extra years are not always healthy ones.

The timing is deliberate. BIO International is one of the biggest life sciences gatherings on the planet, attracting biotech investors, researchers, and health system leaders from around the world. Publishing there means Abu Dhabi is pitching its model directly to the global audience it wants to influence.

What's the news?

Future Health published what it calls the first "Abu Dhabi Blueprint," a whitepaper focused on longevity and healthspan. The report was released at a Future Health Dialogue event held alongside BIO International Convention 2026 in San Diego on 24 June 2026.

The whitepaper was developed with consulting firm EY and identifies four areas Abu Dhabi believes health systems need to address to extend healthy years of life:

• Precision longevity medicine, using genomics and biomarker monitoring to catch disease earlier
• Regenerative and advanced therapeutics
• Citizen empowerment, giving people the tools and environments to make healthier daily choices
• Ecosystem and innovation infrastructure, connecting policy, data, and investment

The report also points to existing infrastructure inside Abu Dhabi's health system, including the Emirati Genome Programme, which aims to sequence one million genomes, and Malaffi, a health information exchange that already connects more than 2,700 healthcare providers across the emirate.

Why does it matter?

The numbers in the whitepaper make the problem hard to ignore. Globally, up to 27% of the extra years people gain through longer lifespans are spent in poor health. In the UAE specifically, non-communicable diseases cause around 55% of all deaths and cost an estimated AED 39.9 billion per year, equivalent to 2.7% of the country's 2019 GDP.

Abu Dhabi's argument is that a system built around prevention and early detection is cheaper and more effective than one that waits for people to get sick. EY research included in the whitepaper backs this up with consumer data from the Gulf region:

• 61% of GCC respondents already use wearable devices to monitor their health
• 55% said AI-based health information had prompted them to seek medical care earlier than they otherwise would have

Those figures suggest the population is already moving toward predictive health, even before governments push them there. For health systems trying to shift from reactive to preventive care, that kind of public readiness matters.

Her Excellency Dr Noura Khamis Al Ghaithi, Undersecretary of the Department of Health in Abu Dhabi, framed it plainly: "The opportunity now is to ensure that health systems are ready to translate these advances into meaningful outcomes."

The context

Abu Dhabi has spent years building the infrastructure for this kind of health ambition. The Emirati Genome Programme, Malaffi's provider network, and heavy investment in AI-driven health tools have all come together over the past decade. This whitepaper is partly a way of packaging that progress into something the global health and investment community can assess and learn from.

The broader industry trend here is real. Health systems across Europe, Asia, and North America are all wrestling with the same demographic and financial pressures. An aging population and a rising burden of chronic disease are straining budgets that were built for acute care, not long-term health management. Countries and cities that figure out how to shift toward prevention and personalised medicine early will have a significant structural advantage.

Future Health is positioning Abu Dhabi as a working example of that shift, not just a wealthy city with good intentions. Whether the model is exportable to health systems with far fewer resources remains an open question, and one the whitepaper does not fully answer. The Abu Dhabi Future Health Summit, scheduled for 20 to 22 October 2026, is where many of these discussions are expected to continue.

The full whitepaper is available to download through Future Health's website.